Preconditioning of intravenous parecoxib attenuates focal cerebral ischemia/reperfusion injury in rats

Chinese Medical Journal

Volumn 124, Issue 13, 2011, Pages 2004-2008

  Wang, Na ^a   Guo, Qu lian ^a   Ye, Zhi ^a   Xia, Ping ping ^a   Wang, E ^a   Yuan, Ya jing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cerebral ischemia; Inflammation; Neuroprotection; Parecoxib

Indexed keywords

CYCLOOXYGENASE 2; HIGH MOBILITY GROUP B1 PROTEIN; PARECOXIB; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SCORING SYSTEM; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; INJECTIONS, INTRAVENOUS; ISOXAZOLES; MALE; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 79960051691     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.13.015     Document Type: Article

References (23)

1. Hurley SD, Olschowka JA, O'Banion MK. Cyclooxygenase inhibition as a strategy to ameliorate brain injury. J Neurotrauma 2002; 19: 1-15.
2. Gilgun-Sherki Y, Melamed E, Offen D. Anti-inflammatory drugs in the treatment of neurodegenerative diseases: current state. Curr Pharm Des 2006; 12: 3509-3519.
3. Sasaki T, Nakagomi T, Kirino T, Tamura A, Noguchi M, Saito I, et al. Indomethacin ameliorates ischemic neuronal damage in the gerbil hippocampal CA1 sector. Stroke 1988; 19: 1399-1403.
4. Nakayama M, Uchimura K, Zhu RL, Nagayama T, Rose ME, Stetler RA, et al. Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc Natl Acad Sci USA 1998; 95: 10954-10959.
5. Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997; 17: 2746-2755.
6. Kelsen J, Kjaer K, Chen G, Pedersen M, Røhl L, Frøkiaer J, et al. Parecoxib is neuroprotective in spontaneously hypertensive rats after transient middle cerebral artery occlusion: a divided treatment response? J Neuroinflammation 2006; 3: 31.
7. Butovas S, Lukkarinen J, Virtanen T, Jolkkonen J, Sivenius J. Differential effect of the alpha2-adrenoceptor antagonist, atipamezole, in limb-placing task and skilled forepaw use following experimental stroke. Restor Neurol Neurosci 2001; 18: 143-151.
8. Yrjänheikki J, Koistinaho J, Kettunen M, Kauppinen RA, Appel K, Hüll M, et al. Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. Brain Res 2005; 1052: 174-179.
9. Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, et al. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods 2003; 122: 201-211.
10. Wang R, Ma WG, Gao GD, Mao QX, Zheng J, Sun LZ, et al. Fluoro Jade-C staining in the assessment of brain injury after deep hypothermia circulatory arrest. Brain Res 2011; 1372: 127-132.
11. Kim JB, Sig Choi J, Yu YM, Nam K, Piao CS, Kim SW, et al. HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J Neurosci 2006; 26: 6413-6421.
12. Huang J, Kim LJ, Mealey R, Marsh HC Jr, Zhang Y, Tenner AJ, et al. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. Science 1999; 285: 595-599.
13. Huttunen HJ, Rauvala H. Amphoterin as an extracellular regulator of cell motility: From discovery to disease. J Intern Med 2004; 255: 351-366.
14. Faraco G, Fossati S, Bianchi ME, Patrone M, Pedrazzi M, Sparatore B, et al. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. J Neurochem 2007; 103: 590-603.
15. Kim JB, Lim CM, Yu YM, Lee JK. Induction and subcellular localization of high-mobility group box-1 (HMGB1)in the postischemic rat brain. J Neurosci Res 2008; 86: 1125-1131.
16. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, et al. Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 2008; 28: 927-938.
17. Sairanen T, Carpén O, Karjalainen-Lindsberg ML, Paetau A, Turpeinen U, Kaste M, et al. Evolution of cerebral tumor necrosis factor-alpha production during human ischemic stroke. Stroke 2001; 32: 1750-1758.
18. Sairanen TR, Lindsberg PJ, Brenner M, Carpén O, Sirén A. Differential cellular expression of tumor necrosis factor-α and Type I tumor necrosis factor receptor after transient global forebrain ischemia. J Neurol Sci 2001; 186: 87-99.
19. Saito K, Suyama K, Nishida K, Sei Y, Basile AS. Early increases in TNF-alpha, IL-6 and IL-1 beta levels following transient cerebral ischemia in gerbil brain. Neurosci Lett 1996; 206: 149-152.
20. Iosif RE, Ekdahl CT, Ahlenius H, Pronk CJ, Bonde S, Kokaia Z, et al. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 2006; 26: 9703-9712.
21. Iosif RE, Ahlenius H, Ekdahl CT, Darsalia V, Thored P, Jovings S, et al. Suppression of stroke-induced progenitor proliferation in adult subventricular zone by tumor necrosis factor receptor 1. J Cereb Blood Flow Metab 2008; 28: 1574-1587.
22. Andersohn F, Schade R, Suissa S, Garbe E. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study. Stroke 2006; 37: 1725-1730.
23. Martínez-González J, Badimon L. Mechanisms underlying the cardiovascular effects of COX-inhibition: benefits and risks. Curr Pharm Des 2007; 13: 2215-2227.